Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
Huapeng Lin, Xinrong Zhang, Guanlin Li, et al.
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Dietary Quality and Relationships with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among United States Adults, Results from NHANES 2017–2018
Ting Tian, Jingxian Zhang, Wei Xie, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4505-4505
Open Access | Times Cited: 70
The prognostic role of diet quality in patients with MAFLD and physical activity: data from NHANES
Jiaofeng Huang, Yinlian Wu, Jiaping Zheng, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
The correlation between heavy metal ions in blood and metabolic dysfunction-associated steatotic liver disease from 1999 to 2018 based on NHANES data
Haijun Ma, Ju Zhao, Jian Xu
Frontiers in Public Health (2025) Vol. 12
Open Access | Times Cited: 1
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Marcello Dallio, Mario Romeo, Filadelfo Nardo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 761-761
Open Access | Times Cited: 1
Elevated small dense low‐density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in Chinese patients with type 2 diabetes mellitus
Shouxing Yang, Jing Xu
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 5, pp. 634-642
Open Access | Times Cited: 6
Exposure to ambient air pollution and metabolic dysfunction-associated fatty liver disease: Findings from over 2.7 million adults in Northwestern China
Weidong Ji, Yinlin Cheng, Shengsheng Tang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 272, pp. 116109-116109
Open Access | Times Cited: 6
A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population
Yacong Zhang, Zhangyan Lyu, Bing Ma, et al.
Hepatology International (2022) Vol. 16, Iss. 4, pp. 835-845
Closed Access | Times Cited: 24
Special Population
Ajay Duseja, Arka De, Vincent Wai‐Sun Wong
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 451-469
Closed Access | Times Cited: 15
Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota
Tianqi Cai, Xinhua Song, Xiaoxue Xu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
The role of pyroptosis in metabolism and metabolic disease
Zhuyuan Zheng, Shaojie Yang, Wanlin Dai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116863-116863
Open Access | Times Cited: 4
Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients with Type 2 Diabetes; A True Game Changer
Qamar Sajad, Khurshid Khan, Aijaz Zeeshan Khan, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 2, pp. 193-198
Closed Access
Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study
Junwei Wang, Chunhua Jin, Jiang-Feng Ke, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Diagnostic Accuracy of the Triglyceride–Glucose Index (TyG), TyG Body Mass Index, and TyG Waist Circumference Index for Liver Steatosis Detection
Alejandra Mijangos-Trejo, Raúl Gómez-Mendoza, Martha Helena Ramos-Ostos, et al.
Diagnostics (2024) Vol. 14, Iss. 7, pp. 762-762
Open Access | Times Cited: 4
Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress
Ziming Mao, Xiaowen Ma, Yu Jing, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 10
Association between dietary carbohydrate to fiber ratio and metabolic dysfunction associated fatty liver disease in adults: evidence from the NHANES 2017–2020
Zhenmin Liu, Taiyong Fang
Journal of Health Population and Nutrition (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients
Lidan Yang, Yuzhao Dai, He He, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 13
Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
Jiaofeng Huang, Ming-Fang Wang, Yinlian Wu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 13
Association of multiple serum minerals and vitamins with metabolic dysfunction-associated fatty liver disease in US adults: National Health and Nutrition Examination Survey 2017–2018
Peisen Guo, Jiahui Yu
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
The LIDPAD Mouse Model Captures the Multisystem Interactions and Extrahepatic Complications in MASLD
Zun Siong Low, Damien Chua, Hong Sheng Cheng, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Dietary patterns in the progression of metabolic dysfunction-associated fatty liver disease to advanced liver disease: a prospective cohort study
Tengfei Li, Jianhui Zhao, Haoze Cao, et al.
American Journal of Clinical Nutrition (2024) Vol. 120, Iss. 3, pp. 518-527
Open Access | Times Cited: 2
XFibrosis: Explicit Vessel-Fiber Modeling for Fibrosis Staging from Liver Pathology Images
Chong Yin, Siqi Liu, Fei Lyu, et al.
2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) (2024) Vol. 21, pp. 11282-11291
Closed Access | Times Cited: 2
Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 12
Metabolically associated fatty liver disease – a disease of the 21st century: A review
И. В. Маев, Д. Н. Андреев, Yu. A. Kucheryavyy
Consilium Medicum (2022) Vol. 24, Iss. 5, pp. 325-332
Open Access | Times Cited: 12
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis
Xinrong Zhang, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, et al.
Hepatology (2023) Vol. 78, Iss. 6, pp. 1816-1827
Closed Access | Times Cited: 6
Association between physical activity and diet quality of obese and non-obese MAFLD
Shuang Wang, Bing Xia, Tingting Luo, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 34, Iss. 1, pp. 75-89
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top